Chemotherapy/immunotherapy combination thwarts glioblastoma in...
Triple combination therapy kills glioblastoma in mice by putting an “eat me” signal to the immune system on the surface of the brain...
Immunotherapy combination stifles pancreatic cancer in...
Combining two immunotherapies caused tumor rejection in mouse models of pancreatic cancer and provided long-term immune memory that...
Acute myeloid leukemia’s minimal residual disease targeted...
In patients with leukemia, complete remission after treatment is currently defined by the absence of cancer cells in a bone marrow...
Triple-negative breast cancer clinical trial allies with community...
Triple-negative breast cancer (TNBC) is an aggressive disease that makes up roughly 15% to 20% of breast cancer diagnoses. Standard...
